Catalyst Wire Dossier Catalyst Wire Dossier

OSPOMYV

Denosumab · Cordavis Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OSPOMYV, covering 2025-02-13 to 2025-10-29. Get the full timeline:

Most recent: FDA Approved: OSPOMYV — Original Application (Cordavis Limited)

See pricing